Sign in
4

Changes in Ownership

Dyne Therapeutics, Inc. Filed Acc 0001915598-26-000005

Chief Commercial Officer sold 1,085 shares at an average $23.42 ($25,408)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Friedl-Naderer Johanna · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-04 Sale : show line 1 in the form 10b5-1 −900 $24.35 $21,915 153,082 D
2026-09-08 Sale : show line 2 in the form 10b5-1 −185 $18.88 $3,493 152,897 D
Open-market sales · 1,085 sh · avg $23.42 · $25,408
Loading xslF345X06/ownership.xml…